415 related articles for article (PubMed ID: 18834246)
1. Bone remodeling biomarkers of periodontal disease in saliva.
Frodge BD; Ebersole JL; Kryscio RJ; Thomas MV; Miller CS
J Periodontol; 2008 Oct; 79(10):1913-9. PubMed ID: 18834246
[TBL] [Abstract][Full Text] [Related]
2. C-telopeptide pyridinoline crosslinks of type I collagen, soluble RANKL, and osteoprotegerin levels in crevicular fluid of dental implants with peri-implantitis: a case-control study.
Arikan F; Buduneli N; Lappin DF
Int J Oral Maxillofac Implants; 2011; 26(2):282-9. PubMed ID: 21483881
[TBL] [Abstract][Full Text] [Related]
3. Salivary interleukin-1β levels in patients with chronic periodontitis before and after periodontal phase I therapy and healthy controls: a case-control study.
Kaushik R; Yeltiwar RK; Pushpanshu K
J Periodontol; 2011 Sep; 82(9):1353-9. PubMed ID: 21235331
[TBL] [Abstract][Full Text] [Related]
4. Effect of locally delivered minocycline microspheres on markers of bone resorption.
Oringer RJ; Al-Shammari KF; Aldredge WA; Iacono VJ; Eber RM; Wang HL; Berwald B; Nejat R; Giannobile WV
J Periodontol; 2002 Aug; 73(8):835-42. PubMed ID: 12211491
[TBL] [Abstract][Full Text] [Related]
5. Salivary osteocalcin levels are decreased in smoker chronic periodontitis patients.
Ozçaka O; Nalbantsoy A; Buduneli N
Oral Dis; 2011 Mar; 17(2):200-5. PubMed ID: 20796231
[TBL] [Abstract][Full Text] [Related]
6. Effect of non-surgical periodontal therapy on C-telopeptide pyridinoline cross-links (ICTP) and interleukin-1 levels.
Al-Shammari KF; Giannobile WV; Aldredge WA; Iacono VJ; Eber RM; Wang HL; Oringer RJ
J Periodontol; 2001 Aug; 72(8):1045-51. PubMed ID: 11525436
[TBL] [Abstract][Full Text] [Related]
7. Bone remodeling-associated salivary biomarker MIP-1α distinguishes periodontal disease from health.
Al-Sabbagh M; Alladah A; Lin Y; Kryscio RJ; Thomas MV; Ebersole JL; Miller CS
J Periodontal Res; 2012 Jun; 47(3):389-95. PubMed ID: 22126530
[TBL] [Abstract][Full Text] [Related]
8. Saliva and serum levels of B-cell activating factors and tumor necrosis factor-α in patients with periodontitis.
Gümüş P; Nizam N; Lappin DF; Buduneli N
J Periodontol; 2014 Feb; 85(2):270-80. PubMed ID: 23701482
[TBL] [Abstract][Full Text] [Related]
9. Salivary antioxidants in patients with type 1 or 2 diabetes and inflammatory periodontal disease: a case-control study.
Gümüş P; Buduneli N; Cetinkalp S; Hawkins SI; Renaud D; Kinane DF; Scott DA
J Periodontol; 2009 Sep; 80(9):1440-6. PubMed ID: 19722794
[TBL] [Abstract][Full Text] [Related]
10. Serum cytokine and periodontal profiles in relation to disease activity of rheumatoid arthritis in Japanese adults.
Kobayashi T; Murasawa A; Komatsu Y; Yokoyama T; Ishida K; Abe A; Yamamoto K; Yoshie H
J Periodontol; 2010 May; 81(5):650-7. PubMed ID: 20429644
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of cytokines in subjects with generalized chronic and aggressive periodontitis before and after non-surgical periodontal therapy: a pilot study.
Duarte PM; da Rocha M; Sampaio E; Mestnik MJ; Feres M; Figueiredo LC; Bastos MF; Faveri M
J Periodontol; 2010 Jul; 81(7):1056-63. PubMed ID: 20192617
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-33 levels in gingival crevicular fluid, saliva, or plasma do not differentiate chronic periodontitis.
Buduneli N; Özçaka Ö; Nalbantsoy A
J Periodontol; 2012 Mar; 83(3):362-8. PubMed ID: 21859321
[TBL] [Abstract][Full Text] [Related]
13. Relationship between salivary leukotriene B4 levels and salivary mucin or alveolar bone resorption, in subjects with periodontal health and disease.
Sánchez GA; Miozza VA; Delgado A; Busch L
J Periodontal Res; 2013 Dec; 48(6):810-4. PubMed ID: 23488687
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor necrosis factor-alpha therapy and periodontal parameters in patients with rheumatoid arthritis.
Mayer Y; Balbir-Gurman A; Machtei EE
J Periodontol; 2009 Sep; 80(9):1414-20. PubMed ID: 19722791
[TBL] [Abstract][Full Text] [Related]
15. Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis.
Kurtiş B; Tüter G; Serdar M; Akdemir P; Uygur C; Firatli E; Bal B
J Periodontol; 2005 Nov; 76(11):1849-55. PubMed ID: 16274303
[TBL] [Abstract][Full Text] [Related]
16. Soluble RANKL in crevicular fluid of dental implants: a pilot study.
Monov G; Strbac GD; Baron M; Kandler B; Watzek G; Gruber R
Clin Implant Dent Relat Res; 2006; 8(3):135-41. PubMed ID: 16919021
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1beta and thiobarbituric acid reactive substance (TBARS) levels after phase I periodontal therapy in patients with chronic periodontitis.
Tüter G; Kurtiş B; Serdar M
J Periodontol; 2001 Jul; 72(7):883-8. PubMed ID: 11495136
[TBL] [Abstract][Full Text] [Related]
18. Significance of elevated gingival crevicular fluid tumor necrosis factor-alpha and interleukin-8 levels in chronic hemodialysis patients with periodontal disease.
Dağ A; Firat ET; Kadiroğlu AK; Kale E; Yilmaz ME
J Periodontal Res; 2010 Aug; 45(4):445-50. PubMed ID: 20337890
[TBL] [Abstract][Full Text] [Related]
19. Salivary IL-1β and PGE2 as biomarkers of periodontal status, before and after periodontal treatment.
Sánchez GA; Miozza VA; Delgado A; Busch L
J Clin Periodontol; 2013 Dec; 40(12):1112-7. PubMed ID: 24118119
[TBL] [Abstract][Full Text] [Related]
20. Salivary MMP-8, TIMP-1, and ICTP as markers of advanced periodontitis.
Gursoy UK; Könönen E; Pradhan-Palikhe P; Tervahartiala T; Pussinen PJ; Suominen-Taipale L; Sorsa T
J Clin Periodontol; 2010 Jun; 37(6):487-93. PubMed ID: 20507371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
